SCHEMBL991335

SCHEMBL991335

O=C1OC2(c3ccc(O)cc3Oc3cc(OP(=O)(O)O)ccc32)c2ccccc21

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 8/20 0.73
MAPT P10636 4/20 0.73
MEN1 O00255 4/20 0.73
KMT2A Q03164 4/20 0.73
TDP1 Q9NUW8 3/20 0.73
HTT P42858 2/20 0.73
HPGD P15428 2/20 0.73
RECQL P46063 2/20 0.73
BLM P54132 2/20 0.73
PRMT1 Q99873 2/20 0.73
ACE2 Q9BYF1 2/20 0.73
CYP2C19 P33261 1/20 0.73
SMAD3 P84022 1/20 0.73
LMNA P02545 3/20 0.60
ALDH1A1 P00352 3/20 0.60
USP2 O75604 2/20 0.60
CYP3A4 P08684 2/20 0.58
ITPR3 Q14573 1/20 0.53
GPR55 Q9Y2T6 2/20 0.53
ALOX12 P18054 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32675203 1.00 FTO (0.73) FTOMAPTMEN1KMT2ATDP1
SCHEMBL17688356 0.99 FTO (0.72) FTOMAPTMEN1KMT2ATDP1
Ammonia Solution, Strong SCHEMBL29101292 0.99 FTO (0.72) FTOMAPTMEN1KMT2ATDP1
Naphthalene SCHEMBL7980446 0.97 FTO (0.69) FTOMAPTMEN1KMT2ATDP1
Fluorescein Diphosphate SCHEMBL29619873 0.94 MAPT (0.67) FTOMAPTMEN1KMT2ATDP1
Fluorescein Diphosphate SCHEMBL106708 0.94 MAPT (0.67) FTOMAPTMEN1KMT2ATDP1
Fluorescein Diphosphate SCHEMBL30035534 0.94 MAPT (0.67) FTOMAPTMEN1KMT2ATDP1
Fluorescein Diphosphate SCHEMBL30767996 0.93 MAPT (0.65) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL5192892 0.92 FTO (0.67) FTOMAPTMEN1KMT2ATDP1
SCHEMBL106709 0.92 FTO (0.67) FTOMAPTMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2676140-A2 SUBSTRATES AND METHODS FOR STAINING LIVE CELLS Life Technologies Corporation (US) 2013-12-25 EP claimed
US-20130323770-A1 SUBSTRATES AND METHODS FOR STAINING LIVE STEM CELLS Life Technologies Corporation (US) 2013-12-05 US claimed
WO-2012112609-A2 SUBSTRATES AND METHODS FOR STAINING LIVE CELLS Life Technologies Corporation (US) 2012-08-23 WO claimed
US-5830666-A USING A FLUORESCEIN DERIVATIVE PHOSPHATE ESTER AISIN SEIKI KABUSHIKI KAISHA (JP) 1998-11-03 US claimed
US-12551555-B2 Compositions and methods for potentiating immune activity KUMQUAT BIOSCIENCES INC. (US) 2026-02-17 US disclosed
US-12385902-B2 Methods for generating and screening compartmentalised peptide libraries UNIVERSITY OF SOUTHAMPTON (GB) 2025-08-12 US disclosed
US-20250195438-A1 LYOPHILIZED MESENCHYMAL STEM CELL DERIVED SECRETOME AND USES THEREOF COMBANGIO, INC. 2025-06-19 US disclosed
US-12186430-B2 Lyophilized mesenchymal stem cell derived secretome and uses thereof COMBANGIO, INC. (US) 2025-01-07 US disclosed
CN-118759190-A Chemiluminescent immunoassay CLIA kit for measuring TPS and method for measuring TPS 泰州泽成生物技术有限公司 2024-10-11 CN disclosed
US-12012632-B2 Methods for obtaining and correcting biological sequence information CYGNUS BIOSCIENCES (BEIJING) CO., LTD (CN) 2024-06-18 US disclosed
US-20240166641-A1 HETEROCYCLES AND USES THEREOF KUMQUAT BIOSCIENCES INC. 2024-05-23 US disclosed
US-20240033297-A1 PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOME COMBANGIO, INC. 2024-02-01 US disclosed
EP-0424465-A4 PREPARATION AND USE OF FLUORESCENT BENZOTHIAZOLE DERIVATIVES 1991-07-03 EP disclosed
EP-0424465-A1 PREPARATION AND USE OF FLUORESCENT BENZOTHIAZOLE DERIVATIVES. JBL SCIENT INC (US) 1991-05-02 EP disclosed
WO-1990000618-A1 PREPARATION AND USE OF FLUORESCENT BENZOTHIAZOLE DERIVATIVES JBL SCIENTIFIC, INC. (US) 1990-01-25 WO disclosed
EP-0070832-A4 MICROENCAPSULATED FLUORESCER COMPOSITION, TEST KIT AND SYSTEM FOR IMMUNOASSAY. ELECTRO NUCLEONICS (US) 1983-06-17 EP disclosed
EP-0070832-A1 MICROENCAPSULATED FLUORESCER COMPOSITION, TEST KIT AND SYSTEM FOR IMMUNOASSAY ELECTRO-NUCLEONICS, INC. (US) 1983-02-09 EP disclosed
US-4372745-A QUALITATIVE AND QUANTITATIVE ANALYSIS ELECTRO-NUCLEONICS, INC. (US) 1983-02-08 US disclosed
WO-1982002772-A1 MICROENCAPSULATED FLUORESCER COMPOSITION,TEST KIT AND SYSTEM FOR IMMUNOASSAY ELECTRO NUCLEONICS (US) 1982-08-19 WO disclosed
WO-1981001883-A1 CHEMICAL LUMINESCENCE AMPLIFICATION SUBSTRATE SYSTEM FOR IMMUNOCHEMISTRY ELECTRO NUCLEONICS (US) 1981-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12551555-B2 Compositions and methods for potentiating immune activity PTPRCAP, PTPN2, PTPRC FTO 1625/4885MAPT 2945/4885MEN1 4405/4885
US-20240166641-A1 HETEROCYCLES AND USES THEREOF KRAS, HRAS, TP53 FTO 4764/4885MAPT 3935/4885MEN1 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.